Voluntary Field Safety Notice Information
Philips Respironics Sleep and Respiratory Care devices
In June 2021, after discovering a potential health risk related to the foam in certain CPAP, BiPAP and Mechanical Ventilator devices, Philips Respironics issued a voluntary Field Safety Notice (outside U.S.) / voluntary recall notification (U.S. only).
News and updates
Philips provides update on Respironics recall
October 6, 2023
Philips response to recent media articles related to Philips Respironics’ voluntary recall notification/field safety notice
September 27, 2023
July 2023 latest results and conclusions for sleep therapy devices related to the impact of ozone cleaning shows no appreciable harm to health in patients
Philips Respironics completed the analyses for System One and DreamStation Go sleep therapy devices indicating that the volatile organic compounds (VOCs) and the particulate matter (PM) emissions related to foam degradation are within the appliable safety limits. Additional visual assessments have been performed and confirm the low prevalence of significant foam degradation.
-
![A conversation with David Ferguson, Business Leader, Sleep and Respiratory Care]()
A conversation with David Ferguson, Business Leader, Sleep and Respiratory Care
June 13, 2023
Click here to learn more -
![Who’s who in the remediation]()
-
![Replacement device safety information]()
-
![Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program]()
Philips provides update on Philips Respironics’ PE-PUR sound abatement foam test and research program
June 28, 2022
Click here to learn more -
![Quick tips about the recall]()
-
![Philips provides update on the test and research program]()
-
![Cleaning and inspection instructions for existing accessories]()
Cleaning and inspection instructions for existing accessories
September 3, 2021
Click here to learn more -
![A message from David Ferguson]()
